UBE2C and adrenal cortex carcinoma: Moreover, in vitro experiments showed that UBE2C knockdown result in poor prognosis of ACC by inhibiting the proliferation, migration, invasion, epithelial–mesenchymal transition (EMT) of adrenocortical carcinoma cells as well as the cell cycle progression.